...
首页> 外文期刊>Drug discovery today >Toxicoproteomics -- a new preclinical tool.
【24h】

Toxicoproteomics -- a new preclinical tool.

机译:毒理蛋白质组学-一种新的临床前工具。

获取原文
获取原文并翻译 | 示例
           

摘要

The publication of the human genome has presented the scientific community with an unprecedented amount of genetic information with the potential to revolutionize the drug discovery process. This information could be used to identify novel drug targets and disease markers or could aid in the development of personalized medicines. The realization that genetic changes must ultimately influence protein function has pushed the field of proteomics further into the limelight. In this review the applications of proteomics to the field of toxicology will be discussed. It is anticipated that, in the future, toxicologists will apply a range of genomic and proteomic techniques to address issues in toxicity.
机译:人类基因组的出版为科学界提供了前所未有的遗传信息,并有可能改变药物发现过程。该信息可用于识别新型药物靶标和疾病标志物,或有助于个性化药物的开发。基因改变必须最终影响蛋白质功能的认识已将蛋白质组学领域进一步引人注目。在这篇综述中,将讨论蛋白质组学在毒理学领域的应用。预计将来,毒理学家将应用一系列基因组学和蛋白质组学技术来解决毒性问题。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号